These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35710563)

  • 1. Extended transit compartment model to describe tumor delay using Coxian distribution.
    Byun JH; Yoon IS; Lee SY; Cho HJ; Jung IH
    Sci Rep; 2022 Jun; 12(1):10086. PubMed ID: 35710563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractional transit compartment model for describing drug delayed response to tumors using Mittag-Leffler distribution on age-structured PKPD model.
    Byun JH; Roh Y; Yoon IS; Kim KS; Jung IH
    PLoS One; 2022; 17(11):e0276654. PubMed ID: 36331932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An alternative formulation of Coxian phase-type distributions with covariates: Application to emergency department length of stay.
    Rizk J; Walsh C; Burke K
    Stat Med; 2021 Mar; 40(6):1574-1592. PubMed ID: 33426678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A two-stage approach to the joint analysis of longitudinal and survival data utilising the Coxian phase-type distribution.
    Donnelly C; McFetridge LM; Marshall AH; Mitchell HJ
    Stat Methods Med Res; 2018 Dec; 27(12):3577-3594. PubMed ID: 28633604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Building mean field ODE models using the generalized linear chain trick & Markov chain theory.
    Hurtado PJ; Richards C
    J Biol Dyn; 2021 May; 15(sup1):S248-S272. PubMed ID: 33847236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distributed transit compartments for arbitrary lifespan distributions in aging populations.
    Koch G; Schropp J
    J Theor Biol; 2015 Sep; 380():550-8. PubMed ID: 26100181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the overdetection of screen-identified cancers in population-based cancer screening with the Coxian phase-type Markov process.
    Yen AM; Chen HH
    Stat Med; 2020 Feb; 39(5):660-673. PubMed ID: 31855293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General relationship between transit compartments and lifespan models.
    Koch G; Schropp J
    J Pharmacokinet Pharmacodyn; 2012 Aug; 39(4):343-55. PubMed ID: 22729453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding Dynamic Status Change of Hospital Stay and Cost Accumulation via Combining Continuous and Finitely Jumped Processes.
    Zheng Y; Zhao X; Zhang X
    Comput Math Methods Med; 2018; 2018():6367243. PubMed ID: 29983729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling of delays in PKPD: classical approaches and a tutorial for delay differential equations.
    Koch G; Krzyzanski W; Pérez-Ruixo JJ; Schropp J
    J Pharmacokinet Pharmacodyn; 2014 Aug; 41(4):291-318. PubMed ID: 25142056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using Coxian phase-type distributions to identify patient characteristics for duration of stay in hospital.
    Marshall AH; McClean SI
    Health Care Manag Sci; 2004 Nov; 7(4):285-9. PubMed ID: 15717813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transit compartments versus gamma distribution function to model signal transduction processes in pharmacodynamics.
    Sun YN; Jusko WJ
    J Pharm Sci; 1998 Jun; 87(6):732-7. PubMed ID: 9607951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpretation of transit compartments pharmacodynamic models as lifespan based indirect response models.
    Krzyzanski W
    J Pharmacokinet Pharmacodyn; 2011 Apr; 38(2):179-204. PubMed ID: 21107661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of parallel Erlang density functions to analyze first-pass pulmonary uptake of multiple indicators in dogs.
    Krejcie TC; Jacquez JA; Avram MJ; Niemann CU; Shanks CA; Henthorn TK
    J Pharmacokinet Biopharm; 1996 Dec; 24(6):569-88. PubMed ID: 9300351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase-type models for competing risks, with emphasis on identifiability issues.
    Lindqvist BH
    Lifetime Data Anal; 2023 Apr; 29(2):318-341. PubMed ID: 35132532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting elderly patient length of stay in hospital and community care using a series of conditional Coxian phase-type distributions, further conditioned on a survival tree.
    Gordon AS; Marshall AH; Zenga M
    Health Care Manag Sci; 2018 Jun; 21(2):269-280. PubMed ID: 28718169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies.
    Savic RM; Jonker DM; Kerbusch T; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2007 Oct; 34(5):711-26. PubMed ID: 17653836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transit and lifespan in neutrophil production: implications for drug intervention.
    Câmara De Souza D; Craig M; Cassidy T; Li J; Nekka F; Bélair J; Humphries AR
    J Pharmacokinet Pharmacodyn; 2018 Feb; 45(1):59-77. PubMed ID: 29236223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generalized stochastic compartmental models with Erlang transit times.
    Matis JH; Wehrly TE
    J Pharmacokinet Biopharm; 1990 Dec; 18(6):589-607. PubMed ID: 2280350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic models of age-structured cell populations.
    Krzyzanski W
    J Pharmacokinet Pharmacodyn; 2015 Oct; 42(5):573-89. PubMed ID: 26377617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.